Home · Open Lab · Lot RGX-26-TESAMORELIN-1046
RGX-26-TESAMORELIN-1046Current
Tesamorelin · 10 MG · Restorative Research · COA NS-2026-05047

Release test results

99.753%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.05 mg
Related impurities (total)0.247%
Endotoxin<1.0 EU/mg
HPLC retention time6.22 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundTesamorelin
Presentation10 MG
Lot numberRGX-26-TESAMORELIN-1046
COA numberNS-2026-05047
Test date16 Jul 2026
Release date19 Jul 2026
Independent labNordicstar Labs
StatusCurrent

Tesamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-TESAMORELIN-1046 this lot10 MGJul 16, 202699.753%Current
RGX-26-TESAMORELIN-104720 MGJul 15, 202699.584%Current
RGX-26-TESAMORELIN-75410 MGApr 14, 202699.736%Superseded
RGX-26-TESAMORELIN-75320 MGApr 7, 202699.646%Superseded
RGX-26-TESAMORELIN-65410 MGJan 7, 202699.684%Superseded
RGX-25-TESAMORELIN-65320 MGDec 28, 202599.667%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →